RESEARCH USE ONLY
70MG
GLOW GHK-CU
70MG · CAS: 49557-75-7
Certificate of Analysis
Batch HPLC & MS included
UK Dispatch
Shipped next working day
Research Grade
≥98% documented purity
Discreet Packaging
Plain, secure, tamper-evident
Laboratory Research Use Only: This compound is sold exclusively for qualified in-vitro scientific and laboratory investigation. Strictly not intended for human or veterinary administration.
Product Overview
GLOW GHK-Cu + BPC-157 + TB-500 is a multi-peptide research formulation combining three compounds that have each been investigated in experimental models involving tissue biology, cellular signalling, wound repair and extracellular-matrix processes.
The formulation brings together GHK-Cu, a copper-binding tripeptide associated with extracellular-matrix and connective-tissue research; BPC-157, a synthetic pentadecapeptide investigated extensively in preclinical tissue-repair models; and TB-500, a research peptide associated with the biologically active region of thymosin beta-4 and investigated in relation to cellular migration, angiogenesis and tissue-repair pathways. Research-Chem.uk supplies GLOW as a laboratory research compound intended strictly for in-vitro, analytical and scientific research applications.
| Key Product Features | |
|---|---|
| Product | GLOW GHK-Cu + BPC-157 + TB-500 |
| Vial | 3ml |
| Total Peptide Content | 70mg |
| Purity | Research-grade peptide blend |
| Testing | HPLC analysis |
| Documentation | Batch-specific Certificate of Analysis (COA) |
| Application | Laboratory research only |
| Dispatch | UK |
What Is GLOW GHK-Cu + BPC-157 + TB-500?
GLOW is a multi-component peptide research formulation containing three distinct research compounds:
GHK-Cu is the copper-associated form of glycyl-L-histidyl-L-lysine (GHK). It has been investigated extensively in extracellular-matrix biology, fibroblast activity, collagen-related processes, wound-healing models and cellular signalling.
BPC-157 is a synthetic pentadecapeptide that has been investigated predominantly in preclinical models. Published research has examined its relationship with wound repair, vascular responses, cellular signalling and tissue-protection mechanisms.
TB-500 is a name commonly used for a synthetic peptide associated with the active region of thymosin beta-4. Research on thymosin beta-4 has investigated actin regulation, cellular migration, angiogenesis and wound-healing processes.
These peptides therefore provide a research model in which multiple biological pathways associated with cellular repair and tissue remodelling can be investigated within the same experimental formulation.
Importantly, the individual peptides remain chemically distinct compounds, and research findings relating to one component should not automatically be attributed to the complete GLOW formulation.
How Is GLOW Investigated in Research?
Research involving the individual components of GLOW has explored several interconnected biological processes.
GHK-Cu
GHK-Cu has been investigated in relation to:
- Fibroblast activity
- Collagen production
- Extracellular-matrix regulation
- Matrix metalloproteinases
- Glycosaminoglycans
- Cellular migration
- Angiogenic signalling
- Wound-healing models
- Oxidative-stress responses
Research reviews describe GHK-Cu as a peptide with substantial preclinical interest in tissue remodelling and repair.
BPC-157
BPC-157 has been investigated primarily in animal and laboratory models involving:
- Wound healing
- Vascular responses
- Tissue repair
- Cellular signalling
- Inflammatory pathways
- Gastrointestinal biology
- Tendon and connective-tissue models
The available literature is predominantly preclinical, with recent reviews highlighting the substantial gap between experimental findings and validated human clinical evidence.
TB-500 / Thymosin Beta-4 Research
Thymosin beta-4 research has investigated mechanisms involving:
- Actin regulation
- Cellular migration
- Angiogenesis
- Fibroblast activity
- Extracellular-matrix remodelling
- Wound closure
- Inflammatory signalling
Research reviews have reported effects across several experimental wound-healing models, although the evidence base varies depending on whether the study concerns full-length thymosin beta-4 or the TB-500-associated peptide fragment.
GLOW GHK-Cu + BPC-157 + TB-500 Research Applications
Tissue-Repair Research
The three components of GLOW have individually been investigated in experimental models involving tissue repair. GHK-Cu research focuses strongly on extracellular-matrix regulation and fibroblast biology, while BPC-157 and thymosin beta-4 research has investigated cellular responses associated with tissue recovery. This makes the blend relevant to laboratory studies examining interconnected tissue-repair pathways.
Extracellular-Matrix Research
GHK-Cu provides a particularly useful model for studying extracellular-matrix biology. Research has examined collagen production, proteoglycans, glycosaminoglycans and matrix metalloproteinase activity following GHK/GHK-Cu exposure. The inclusion of multiple peptides allows researchers to investigate how different peptide-associated signalling pathways may interact within experimental models of matrix remodelling.
Fibroblast and Cellular-Migration Research
Fibroblasts are central to extracellular-matrix production and tissue remodelling. GHK-Cu has been studied in fibroblast systems, while thymosin beta-4 research has investigated cellular migration and cytoskeletal processes associated with actin dynamics.
Angiogenesis Research
Angiogenesis is an important component of tissue repair and remodelling. Research involving GHK-Cu and thymosin beta-4 has investigated endothelial-cell activity and signalling pathways associated with new blood-vessel formation. BPC-157 has also been investigated in preclinical models involving vascular responses and angiogenic mechanisms.
Wound-Healing Research
All three components have appeared in experimental research relating to wound biology, although the quantity and quality of evidence differ substantially between compounds. GHK-Cu research has investigated collagen deposition, fibroblast activation, angiogenesis and wound contraction, while thymosin beta-4 has been studied in models of wound closure and tissue repair. BPC-157 has also demonstrated biological activity in numerous animal wound models.
Cellular Signalling Research
The GLOW formulation may also be used as a research model for examining multiple peptide-associated signalling pathways simultaneously. Potential areas of investigation include:
- Cytoskeletal signalling
- Extracellular-matrix turnover
- Cellular migration
- Fibroblast signalling
- Vascular signalling
- Inflammatory pathways
- Oxidative-stress responses
- Tissue-remodelling mechanisms
What Does the Research Say?
The scientific rationale behind GLOW comes from the individual research profiles of its three components, rather than from clinical evidence specifically evaluating the combined GHK-Cu + BPC-157 + TB-500 formulation.
GHK-Cu has one of the more established experimental research histories of the three components in relation to extracellular-matrix biology. Research has reported effects involving collagen, fibroblasts, proteoglycans, matrix metalloproteinases and wound-healing responses.
BPC-157 has generated extensive preclinical literature, particularly involving wound and tissue-repair models. However, recent scientific reviews continue to emphasise that the majority of evidence remains preclinical and that significant translational and pharmaceutical-development questions remain unresolved.
Thymosin beta-4 research has produced evidence relating to actin regulation, cellular migration, angiogenesis and wound repair. Reviews have described activity across multiple experimental models while also noting the need for further research to establish the clinical relevance of these findings.
A recent 2026 review examining several emerging peptides, including BPC-157, GHK-Cu and TB-500, concluded that much of the available literature consists of preclinical work and that robust human efficacy and safety data remain limited.
For this reason, GLOW is best positioned as a multi-peptide laboratory research formulation for investigating complementary biological pathways rather than as a clinically validated therapeutic product.
Research References
-
Pickart L, et al. (2008). The human tri-peptide GHK and tissue remodeling. Journal of Biomaterials Science, Polymer Edition.
PMID: 18644225
-
Pickart L, Margolina A. (2018). Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. International Journal of Molecular Sciences, 19(7), 1987.
PMID: 29986520
- BPC-157 Research Review. Stable Gastric Pentadecapeptide BPC 157 and Wound Healing. Review of experimental BPC-157 research involving wound-healing and tissue-repair models.
- Thymosin Beta-4 Research Review. Research advances on thymosin β4 in promoting wound healing. Review of thymosin beta-4 molecular mechanisms, angiogenesis and experimental wound repair.
- Progress on the Function and Application of Thymosin β4. Review covering actin regulation, cellular migration, angiogenesis and wound-healing research involving thymosin beta-4.
- Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance (2026). Recent review examining BPC-157, GHK-Cu, TB-500 and other emerging peptide compounds, with particular emphasis on the limitations of current human evidence.
Researchers should consult the original publications when assessing experimental methodology, results, limitations and the distinction between individual peptide components and the combined formulation.
GLOW GHK-Cu + BPC-157 + TB-500 Product Specifications
| Specification | Details |
|---|---|
| Product Name | GLOW GHK-Cu + BPC-157 + TB-500 |
| Vial Size | 3ml |
| Total Peptide Content | 70mg |
| Purity | Research-grade peptide blend |
| Components | GHK-Cu + BPC-157 + TB-500 |
| Testing Method | HPLC |
| Physical Form | Lyophilised peptide blend |
| Intended Application | Laboratory research only |
| Documentation | Batch-specific COA |
The 70mg specification represents the total peptide content of the formulation. Individual component quantities are not stated here as the specific GHK-Cu/BPC-157/TB-500 formulation ratio has not been provided.
Quality and Purity
At Research-Chem.uk, analytical quality and batch traceability are central to our research peptide range.
GLOW GHK-Cu + BPC-157 + TB-500 is supplied as a defined 70mg multi-peptide research formulation in a 3ml vial. HPLC analysis is used as part of the analytical quality-control process, with batch-specific documentation available to support laboratory identification and research records.
Each supplied batch is accompanied by Certificate of Analysis (COA) documentation. For multi-component peptide formulations, researchers should refer to the relevant batch documentation for the analytical characteristics of the individual components and overall formulation.
Laboratory Research Applications
GLOW GHK-Cu + BPC-157 + TB-500 may be suitable for laboratory investigations involving:
- Tissue-remodelling research
- Extracellular-matrix biology
- Fibroblast research
- Collagen-related studies
- Cellular migration
- Angiogenesis research
- Wound-healing models
- Vascular signalling
- Inflammatory signalling
- Oxidative-stress research
- Cytoskeletal biology
- Matrix metalloproteinase research
- Peptide interaction studies
- Multi-peptide experimental models
- Analytical peptide research
The formulation is supplied strictly as a research compound and is not intended to diagnose, treat, cure or prevent any disease or medical condition.
Why Choose Research-Chem.uk?
Research-Chem.uk provides research peptides and peptide formulations for laboratories, analytical researchers and other qualified research environments. Our range focuses on:
HPLC-Verified Materials
Peptide products are subjected to analytical purity assessment, with batch-specific documentation available.
Batch Traceability
Products are supplied with Certificate of Analysis documentation to support laboratory record keeping and material identification.
UK Dispatch
Research compounds are dispatched from the UK for efficient domestic delivery.
Research-Only Positioning
Products are supplied exclusively for legitimate laboratory research and analytical applications.
Clear Product Specifications
Each product page provides defined information about peptide content, formulation and relevant research characteristics.
Research-Use Disclaimer
For laboratory research use only. Not for human or veterinary use.
GLOW GHK-Cu + BPC-157 + TB-500 supplied by Research-Chem.uk is intended strictly for in-vitro laboratory research, analytical testing and scientific investigation.
This product is not a medicine, pharmaceutical preparation, dietary supplement or food product. It is not intended for human consumption, self-administration, diagnosis, treatment, cure or prevention of any disease or medical condition.
The scientific information provided on this page describes published research involving the individual peptide components and should not be interpreted as evidence that the complete GLOW formulation has been clinically evaluated.
Researchers and laboratories are responsible for ensuring that all use, handling, storage, testing and disposal procedures comply with applicable legislation, institutional requirements and laboratory safety protocols.
For qualified researchers and controlled laboratory research use only.
